Bone Marrow Transplantation - Table of Contents alert Volume 51 Issue 8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 51, Issue 8 (August 2016) In this issue Perspective Reviews Special Report Commentaries Original Articles Letters to the Editor Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Marking 30 years of BMT publishing excellence - 1986 to 2016  Springer Nature is pleased to mark 30 years of Bone Marrow Transplantation journal publishing. We are commemorating the anniversary by giving everyone access to the  10 most cited BMT articles of all time and publishing an editorial by original editor Robert Gale that looks back over the journal's history.     Perspective Top What do we need to know about allogeneic hematopoietic stem cell transplant survivors? C A Clark, M Savani, M Mohty and B N Savani Bone Marrow Transplant 2016 51: 1025-1031; advance online publication, April 11, 2016; 10.1038/bmt.2016.95 Abstract | Full Text Reviews Top Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma M Martino, R M Lemoli, C Girmenia, L Castagna, B Bruno, F Cavallo, M Offidani, I Scortechini, M Montanari, G Milone, L Postacchini and A Olivieri Bone Marrow Transplant 2016 51: 1032-1040; advance online publication, April 4, 2016; 10.1038/bmt.2016.79 Abstract | Full Text How do I manage hyperglycemia/post-transplant diabetes mellitus after allogeneic HSCT S Fuji, A Rovó, K Ohashi, M Griffith, H Einsele, M Kapp, M Mohty, N S Majhail, B G Engelhardt, A Tichelli and B N Savani Bone Marrow Transplant 2016 51: 1041-1049; advance online publication, April 4, 2016; 10.1038/bmt.2016.81 Abstract | Full Text Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis C Saillard, D Blaise and D Mokart Bone Marrow Transplant 2016 51: 1050-1061; advance online publication, April 4, 2016; 10.1038/bmt.2016.72 Abstract | Full Text Special Report Top Development, preliminary usability and accuracy testing of the EBMT ‘eGVHD App’ to support GvHD assessment according to NIH criteria—a proof of concept H Schoemans, K Goris, R V Durm, J Vanhoof, D Wolff, H Greinix, S Pavletic, S J Lee, J Maertens, S D Geest, F Dobbels and R F Duarte for the EBMT Complications and Quality of Life Working Party Bone Marrow Transplant 2016 51: 1062-1065; advance online publication, April 4, 2016; 10.1038/bmt.2016.26 Abstract | Full Text Commentaries Top Transplants for MDS and quality-of-life. But whose quality-of-life? R P Gale and I Pusic Bone Marrow Transplant 2016 51: 1066-1068; advance online publication, June 6, 2016; 10.1038/bmt.2016.147 Full Text Hematopoietic cell transplantation in MDS: undervalued and underutilized M R Grunwald, B R Avalos and E A Copelan Bone Marrow Transplant 2016 51: 1069-1070; advance online publication, June 20, 2016; 10.1038/bmt.2016.169 Full Text Antibiotic prophylaxis in allogeneic stem cell transplantation—what is the correct choice? R R Jenq and M R M van den Brink Bone Marrow Transplant 2016 51: 1071-1072; advance online publication, May 23, 2016; 10.1038/bmt.2016.144 Full Text Lost in Transplantation? Unexpected shift from multipotent to late lymphomyeloid hematopoietic stem and progenitor cells in patients 1 year after hematopoietic stem cell transplantation A Görgens, F Murke, L Kordelas and B Giebel Bone Marrow Transplant 2016 51: 1073-1075; advance online publication, May 23, 2016; 10.1038/bmt.2016.146 Full Text Original Articles Top SOLID CANCERS Busulfan–melphalan in high-risk neuroblastoma: the 30-year experience of a single institution S Proust-Houdemont, C Pasqualini, P Blanchard, C Dufour, E Benhamou, G Goma, M Semeraro, M-A Raquin, O Hartmann and D Valteau-Couanet Bone Marrow Transplant 2016 51: 1076-1081; advance online publication, April 4, 2016; 10.1038/bmt.2016.75 Abstract | Full Text Highly favorable outcome in BRCA-mutated metastatic breast cancer patients receiving high-dose chemotherapy and autologous hematopoietic stem cell transplantation L Boudin, A Gonçalves, R Sabatier, J Moretta, P Sfumato, P Asseeva, D Livon, F Bertucci, J-M Extra, C Tarpin, G Houvenaegel, E Lambaudie, A Tallet, M Resbeut, H Sobol, E Charafe-Jauffret, B Calmels, C Lemarie, J-M Boher, P Viens, F Eisinger and C Chabannon Bone Marrow Transplant 2016 51: 1082-1086; advance online publication, April 4, 2016; 10.1038/bmt.2016.82 Abstract | Full Text SUPPORTIVE CARE Rifaximin preserves intestinal microbiota balance in patients undergoing allogeneic stem cell transplantation D Weber, P J Oefner, K Dettmer, A Hiergeist, J Koestler, A Gessner, M Weber, F Stämmler, J Hahn, D Wolff, W Herr and E Holler Bone Marrow Transplant 2016 51: 1087-1092; advance online publication, March 21, 2016; 10.1038/bmt.2016.66 Abstract | Full Text GRAFT SOURCE Multi-color immune-phenotyping of CD34 subsets reveals unexpected differences between various stem cell sources J Dmytrus, S Matthes-Martin, H Pichler, N Worel, R Geyeregger, N Frank, C Frech and G Fritsch Bone Marrow Transplant 2016 51: 1093-1100; advance online publication, April 4, 2016; 10.1038/bmt.2016.88 Abstract | Full Text TRANSPLANT TOXICITIES Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors P Anandi, N A Jain, X Tian, C O Wu, P A Pophali, E Koklanaris, S Ito, B N Savani, J Barrett and M Battiwalla Bone Marrow Transplant 2016 51: 1101-1106; advance online publication, April 4, 2016; 10.1038/bmt.2016.85 Abstract | Full Text GRAFT-VERSUS-HOST DISEASE Lymphodepleting chemotherapy with donor lymphocyte infusion post-allogeneic HCT for hematological malignancies is associated with severe, but therapy-responsive aGvHD F He, E Warlick, J S Miller, M MacMillan, M R Verneris, Q Cao and D Weisdorf Bone Marrow Transplant 2016 51: 1107-1112; advance online publication, April 11, 2016; 10.1038/bmt.2016.63 Abstract | Full Text INFECTIONS Impact of early CMV reactivation in cord blood stem cell recipients in the current era M Ramanathan, P Teira, M Battiwalla, J Barrett, K W Ahn, M Chen, J Green, M Laughlin, H M Lazarus, D Marks, A Saad, M Seftel, W Saber, B Savani, E K Waller, J Wingard, J J Auletta, C A Lindemans, M Boeckh and M L Riches for the Infection and Immune Reconstitution Working Committee of the Center for International Blood & Marrow Transplant Research Bone Marrow Transplant 2016 51: 1113-1120; advance online publication, April 4, 2016; 10.1038/bmt.2016.89 Abstract | Full Text QOL AND PATIENTS' CARE Does quality of life impact the decision to pursue stem cell transplantation for elderly patients with advanced MDS? A El-Jawahri, H T Kim, D P Steensma, A M Cronin, R M Stone, C D Watts, Y-B Chen, C S Cutler, R J Soiffer and G A Abel Bone Marrow Transplant 2016 51: 1121-1126; advance online publication, March 21, 2016; 10.1038/bmt.2016.40 Abstract | Full Text Letters to the Editor Top Recovery of physical function and quality of life in patients undergoing hematopoietic stem cell transplantation: a 1-year follow-up T Takekiyo, K Dozono, T Mitsuishi, S Nara, K Yoshida, Y Murayama, A Maeda, T Chaen, N Nakano, A Kubota, M Tokunaga, S Takeuchi, Y Takatsuka and A Utsunomiya Bone Marrow Transplant 2016 51: 1127-1130; advance online publication, March 21, 2016; 10.1038/bmt.2016.58 Full Text Insufficient immune reconstitution after allogeneic cord blood transplantation without chemotherapy conditioning in patients with SCID caused by CD3δ deficiency H Takada, M Ishimura and T Hara Bone Marrow Transplant 2016 51: 1131-1133; advance online publication, March 21, 2016; 10.1038/bmt.2016.64 Full Text The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide R Crocchiolo, L Castagna, S Furst, R Devillier, B Sarina, S Bramanti, J El-Cheikh, A Granata, S Harbi, L Morabito, C Faucher, A Rimondo, D Girardi, B Mohty, B Calmels, C Carlo-Stella, C Chabannon, R Bouabdallah, A Santoro, N Vey, P J Weiller and D Blaise Bone Marrow Transplant 2016 51: 1134-1136; advance online publication, March 21, 2016; 10.1038/bmt.2016.69 Full Text Evaluation of EPI-X4 as a urinary peptide biomarker for diagnosis and prognosis of late acute GvHD J A Müller, O Zirafi, N R Roan, S J Lee and J Münch Bone Marrow Transplant 2016 51: 1137-1139; advance online publication, April 4, 2016; 10.1038/bmt.2016.65 Full Text Long-term follow-up of 90Y-ibritumomab-tiuxetan (90YIT) in the conditioning of autologous hematopoietic transplantation for indolent and mantle cell lymphomas in a single French center L Philippe, P Helias, M Puyraveau, H Boulahdour, E Deconinck and E Daguindau Bone Marrow Transplant 2016 51: 1140-1142; advance online publication, April 4, 2016; 10.1038/bmt.2016.67 Full Text Assessment of tumoral plasma cells in apheresis products for autologous stem cell transplantation in multiple myeloma S Wuillème, A Lok, N Robillard, P Dupuis, V Stocco, H Migné, A Dusquesne, C Touzeau, M Tiab, M C Béné and P Moreau Bone Marrow Transplant 2016 51: 1143-1145; advance online publication, April 4, 2016; 10.1038/bmt.2016.74 Full Text Evolution of serum cytokine profile after hematopoietic stem cell transplantation in systemic sclerosis patients L Michel, D Farge, J Baraut, Z Marjanovic, F Jean-Louis, R Porcher, E I Grigore, C Deligny, F Romijn, L C M Arruda, J van Pelt, N Levarht, F Verrecchia and J M van Laar Bone Marrow Transplant 2016 51: 1146-1149; advance online publication, April 4, 2016; 10.1038/bmt.2016.77 Full Text Longer delay of hematological recovery and increased transfusion needs after haploidentical compared to non-haploidentical stem cell transplantation A Desjonqueres, M Illiaquer, A Duquesne, Y Le Bris, P Peterlin, T Guillaume, J Delaunay, F Rialland, P Moreau, M C Béné, P Chevallier and M Eveillard Bone Marrow Transplant 2016 51: 1150-1152; advance online publication, April 4, 2016; 10.1038/bmt.2016.80 Full Text Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD S-K Tey, S Vuckovic, A Varelias, J P Martins, S Olver, L Samson, E Sturgeon, J Leach, J Avery, M Nakagaki, J P Butler, C Curley, A J Morton, S T Durrant, G A Kennedy and G R Hill Bone Marrow Transplant 2016 51: 1153-1155; advance online publication, April 4, 2016; 10.1038/bmt.2016.83 Full Text Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy W I Gonsalves, S V Rajkumar, M A Gertz, A Dispenzieri, M Q Lacy, F K Buadi, D Dingli, R S Go, N Leung, P Kapoor, S R Hayman, J A Lust, S J Russell, S R Zeldenrust, Y L Hwa, T V Kourelis, R A Kyle and S K Kumar Bone Marrow Transplant 2016 51: 1156-1158; advance online publication, April 11, 2016; 10.1038/bmt.2016.91 Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.